Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2021-07-16 00:00:00 ET · period of report 2021-07-15 · accession 0001214659-21-007588 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-16 | 2021-07-15 | ALLO | Bhavnagri Veer | GC | S - Sale+OE | $21.55 | -5,000 | 421.4K | -1% | -$107.8K |
| D | 2021-07-16 | 2021-07-15 | ALLO | Bhavnagri Veer | GC | M - OptEx | $2.27 | +5,000 | 426.4K | +1% | +$11.3K |
| D | 2021-07-16 | 2021-07-15 | ALLO | Bhavnagri Veer | GC | M - OptEx | $0.00 | -5,000 | 122.3K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-15 | S | D | 5,000 | $21.55 | 421,353 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.34 to $21.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 2 | Common | Common Stock | 2021-07-15 | M | A | 5,000 | $2.27 | 426,353 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-07-15 | M | D | 5,000 | $0.00 | 122,300 | D | $2.27 · — to 2028-06-25 | 5,000 Common Stock | (F3) 25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. |